Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cholesterol Lowering Biologic Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cholesterol Lowering Biologic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Cholesterol Lowering Biologic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Regeneron Pharmaceuticals
Amgen
Alnylam Pharmaceuticals
By Type:
For Oral Administration
Injectable Drugs
By End-User:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholesterol Lowering Biologic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of For Oral Administration from 2016 to 2027
-
1.3.2 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Injectable Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
1.4.4 USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cholesterol Lowering Biologic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cholesterol Lowering Biologic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of For Oral Administration
-
3.4.2 Market Size and Growth Rate of Injectable Drugs
4 Segmentation of Cholesterol Lowering Biologic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cholesterol Lowering Biologic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Drug Stores
-
4.4.4 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Online Sales
5 Market Analysis by Regions
-
5.1 USA Cholesterol Lowering Biologic Drugs Production Analysis by Regions
-
5.2 USA Cholesterol Lowering Biologic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Cholesterol Lowering Biologic Drugs Landscape Analysis
-
6.1 West USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
6.2 West USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
7 South USA Cholesterol Lowering Biologic Drugs Landscape Analysis
-
7.1 South USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
7.2 South USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
8 Middle West USA Cholesterol Lowering Biologic Drugs Landscape Analysis
-
8.1 Middle West USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
9 Northeast USA Cholesterol Lowering Biologic Drugs Landscape Analysis
-
9.1 Northeast USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Regeneron Pharmaceuticals
-
10.1.1 Regeneron Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Amgen
-
10.2.1 Amgen Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Alnylam Pharmaceuticals
-
10.3.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of For Oral Administration from 2016 to 2027
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Injectable Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
Figure USA Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cholesterol Lowering Biologic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cholesterol Lowering Biologic Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cholesterol Lowering Biologic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Cholesterol Lowering Biologic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of For Oral Administration
-
Figure Market Size and Growth Rate of Injectable Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cholesterol Lowering Biologic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cholesterol Lowering Biologic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Drug Stores
-
Figure Market Size and Growth Rate of Online Sales
-
Table USA Cholesterol Lowering Biologic Drugs Production by Regions
-
Table USA Cholesterol Lowering Biologic Drugs Production Share by Regions
-
Figure USA Cholesterol Lowering Biologic Drugs Production Share by Regions in 2016
-
Figure USA Cholesterol Lowering Biologic Drugs Production Share by Regions in 2021
-
Figure USA Cholesterol Lowering Biologic Drugs Production Share by Regions in 2027
-
Table USA Cholesterol Lowering Biologic Drugs Consumption by Regions
-
Table USA Cholesterol Lowering Biologic Drugs Consumption Share by Regions
-
Figure USA Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2016
-
Figure USA Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2021
-
Figure USA Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2027
-
Table West USA Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table West USA Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table South USA Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table South USA Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table South USA Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure South USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Middle West USA Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Northeast USA Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Regeneron Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals
-
Table Product and Service Introduction of Regeneron Pharmaceuticals
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
